Stemtech OTC Stock Today


USD 0.16  0.01  6.67%   

Market Performance
0 of 100
Odds Of Distress
Over 53
Stemtech is trading at 0.16 as of the 7th of December 2022. This is a 6.67 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.14. Stemtech has 53 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Stemtech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of October 2022 and ending today, the 7th of December 2022. Click here to learn more.
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands. The company has 48.63 M outstanding shares of which 0 shares are at this time shorted by private and institutional investors with about 0.0 trading days to cover. More on Stemtech

Moving together with Stemtech

+0.71TLKTelkom Indonesia Tbk Downward RallyPairCorr

Moving against Stemtech

-0.63PPERYBank Mandiri Persero Normal TradingPairCorr
-0.56ABBVAbbVie Inc Sell-off TrendPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Stemtech OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Stemtech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Stemtech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Stemtech generated a negative expected return over the last 90 days
Stemtech has high historical volatility and very poor performance
Stemtech has some characteristics of a very speculative penny stock
Stemtech has high likelihood to experience some financial distress in the next 2 years
The company currently holds 219.47 K in liabilities. Stemtech has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Stemtech until it has trouble settling it off, either with new capital or with free cash flow. So, Stemtech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Stemtech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Stemtech to invest in growth at high rates of return. When we think about Stemtech's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 4.32 M. Net Loss for the year was (7.08 M) with profit before overhead, payroll, taxes, and interest of 3.3 M.
Stemtech currently holds about 399.73 K in cash with (1.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 64.0% of the company outstanding shares are owned by corporate insiders
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Stemtech's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Stemtech [STEK] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Stemtech's market, we take the total number of its shares issued and multiply it by Stemtech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Stemtech conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 48.63 M outstanding shares of which 0 shares are at this time shorted by private and institutional investors with about 0.0 trading days to cover. Stemtech currently holds about 399.73 K in cash with (1.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Stemtech Probability Of Bankruptcy
Stemtech maintains a total of 48.63 Million outstanding shares. Stemtech has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company outstanding shares. 63.6 % of Stemtech outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Stemtech Ownership Details

Stemtech Stock Price Odds Analysis

Coming from a normal probability distribution, the odds of Stemtech jumping above the current price in 90 days from now is about 74.89%. The Stemtech probability density function shows the probability of Stemtech otc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Stemtech has a beta of -0.0241. This usually implies as returns on benchmark increase, returns on holding Stemtech are expected to decrease at a much lower rate. During the bear market, however, Stemtech is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Stemtech is significantly underperforming NYSE Composite.
  Odds Below 0.16HorizonTargetOdds Above 0.16
25.07%90 days
Based on a normal probability distribution, the odds of Stemtech to move above the current price in 90 days from now is about 74.89 (This Stemtech probability density function shows the probability of Stemtech OTC Stock to fall within a particular range of prices over 90 days) .

Stemtech Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Stemtech market risk premium is the additional return an investor will receive from holding Stemtech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Stemtech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Stemtech's alpha and beta are two of the key measurements used to evaluate Stemtech's performance over the market, the standard measures of volatility play an important role as well.

Stemtech Stock Against Markets

Picking the right benchmark for Stemtech otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Stemtech otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Stemtech is critical whether you are bullish or bearish towards Stemtech at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Stemtech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Valuation Now


Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Stemtech Corporate Management

Elected by the shareholders, the Stemtech's board of directors comprises two types of representatives: Stemtech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stemtech. The board's role is to monitor Stemtech's management team and ensure that shareholders' interests are well served. Stemtech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stemtech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Charles Arnold - CEO DirectorProfile
James Cardwell - Chief OfficerProfile
Alejandro Carrillo - Managing MarketsProfile
John Meyer - COO PresProfile

Invested in Stemtech?

The danger of trading Stemtech is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Stemtech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Stemtech. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Stemtech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, take a look at World Market Map. Note that the Stemtech information on this page should be used as a complementary analysis to other Stemtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for Stemtech OTC Stock analysis

When running Stemtech price analysis, check to measure Stemtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stemtech is operating at the current time. Most of Stemtech's value examination focuses on studying past and present price action to predict the probability of Stemtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Stemtech's price. Additionally, you may evaluate how the addition of Stemtech to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Please note, there is a significant difference between Stemtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Stemtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stemtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.